Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.655 AUD 0.77% Market Closed
Market Cap: 225.9m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note

EV/OCF
Enterprise Value to OCF

-30.8
Current
-28.9
Median
5.7
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-30.8
=
Enterprise Value
204.1m AUD
/
Operating Cash Flow
-7.4m NZD
All Countries
Close
Market Cap EV/OCF
NZ
Aroa Biosurgery Ltd
ASX:ARX
225.5m AUD -30.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 317.7
US
Abbvie Inc
NYSE:ABBV
312.7B USD 22
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD -128.5
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 10.7
US
Epizyme Inc
F:EPE
94.1B EUR -470.5
AU
CSL Ltd
ASX:CSL
133.6B AUD 34.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 17.8
US
Seagen Inc
F:SGT
39.3B EUR -73.6
NL
argenx SE
XBRU:ARGX
34.5B EUR -126.8
 
NZ
Aroa Biosurgery Ltd
ASX:ARX
Average EV/OCF: 22.8
Negative Multiple: -30.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 317.7
US
Abbvie Inc
NYSE:ABBV
22
US
Amgen Inc
NASDAQ:AMGN
28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -128.5
US
Gilead Sciences Inc
NASDAQ:GILD
10.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.5
AU
CSL Ltd
ASX:CSL
34.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More